SynthesisFrontiers in oncology2020

Six Months vs. 12 Months of Adjuvant Trastuzumab Among Women With HER2-Positive Early-Stage Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.

Huan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.